Literature DB >> 24704686

miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.

Yi Zhang1, Dayong Zheng2, Yan Xiong1, Chengbiao Xue1, Gen Chen1, Bibo Yan1, Qifa Ye3.   

Abstract

MicroRNAs have emerged as important regulators of carcinogenesis. In the current study, we observed that microRNA-202 (miR-202) is downregulated in hepatocellular carcinoma (HCC) cells and tissues, indicating a significant correlation between miR-202 expression and HCC progression. Overexpression of miR-202 in HCC cells suppressed cell proliferation and tumorigenicity, while downregulation of miR-202 enhanced the cells' proliferative capacity. Furthermore, we identified low-density lipoprotein receptor-related protein 6 (LRP6) as a direct target of miR-202. miR-202 suppresses the expression of LRP6 by binding to the 3'-untranslated region (UTR) of its mRNA. Finally, we found that silencing the expression of LRP6 is the essential biological function of miR-202 during HCC cell proliferation. Collectively, our findings reveal that miR-202 is a potential tumor suppressive miRNA that participates in carcinogenesis of human HCC by suppressing LRP6 expression.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Hepatocellular carcinoma; Proliferation; lipoprotein receptor-related protein 6; microRNA-202

Mesh:

Substances:

Year:  2014        PMID: 24704686     DOI: 10.1016/j.febslet.2014.03.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  33 in total

1.  TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.

Authors:  Zaijun Lin; Dianwen Song; Haifeng Wei; Xinghai Yang; Tielong Liu; Wangjun Yan; Jianru Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-15       Impact factor: 4.553

2.  miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2.

Authors:  Zhengwen Sun; Tongqing Zhang; Huanyu Hong; Qingxia Liu; Haiguang Zhang
Journal:  Mol Cell Biochem       Date:  2014-08-26       Impact factor: 3.396

3.  miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.

Authors:  Shengping Zhang; Jiarong Cai; Wenjun Xie; Hui Luo; Fei Yang
Journal:  Exp Ther Med       Date:  2018-06-12       Impact factor: 2.447

Review 4.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

5.  PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.

Authors:  Xiaohong Chen; Bo Song; Yuanlong Lin; Lijun Cao; Shiyan Feng; Lin Zhang; Fuxiang Wang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

6.  miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer.

Authors:  Hardik R Mody; Sau Wai Hung; Rakesh K Pathak; Jazmine Griffin; Zobeida Cruz-Monserrate; Rajgopal Govindarajan
Journal:  Mol Cancer Res       Date:  2017-04-03       Impact factor: 5.852

7.  Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells.

Authors:  Lulu Farhana; Marcia I Dawson; Joseph A Fontana
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

8.  Low expression of microRNA-202 is associated with the metastasis of esophageal squamous cell carcinoma.

Authors:  Guoliang Ma; Fengmei Zhang; Xueguang Dong; Xiaoli Wang; Yuguo Ren
Journal:  Exp Ther Med       Date:  2016-01-21       Impact factor: 2.447

9.  miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.

Authors:  Jun Xue; Yan-Feng Niu; Jing Huang; Gang Peng; Li-Xia Wang; Yu-Hui Yang; Yun-Qiao Li
Journal:  Tumour Biol       Date:  2014-08-21

10.  An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma.

Authors:  Yong Yang; Dianbo Li; Yang Yang; Gening Jiang
Journal:  Mol Med Rep       Date:  2015-03-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.